BBI Life Sciences Corporation reported audited consolidated earnings results for the year ended December 31, 2015. For the period, the company has posted revenue of approximately RMB 282.39 million, representing an increase of 11.5% as compared with RMB 253.19 million for the same period of 2014. Profit attributable to equity holders of the company increased by 51.2% from approximately RMB 33.29 million for the same period of 2014 to approximately RMB 50.34 million.

Operating profit was RMB 52.079 million against RMB 17.68 million a year ago. Profit before income tax was RMB 57.55 million against RMB 47.27 million a year ago. Diluted per share was RMB 0.093 against RMB 0.084 a year ago.